Drug treatment of hypertension.
D003000:Clonidine / Q000627:therapeutic use; D003981:Diazoxide / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008464:Mecamylamine / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D000451:Mineralocorticoid Receptor Antagonists; D008914:Minoxidil / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D046948:Secologanin Tryptamine Alkaloids / Q000627:therapeutic use; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use; D014294:Trimethaphan / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D004232:Diuretics; D005730:Ganglionic Blockers; D000451:Mineralocorticoid Receptor Antagonists; D046948:Secologanin Tryptamine Alkaloids; D049993:Sodium Chloride Symporter Inhibitors; D013565:Sympatholytics; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; D013148:Spironolactone; D008750:Methyldopa; D008914:Minoxidil; D008464:Mecamylamine; D014294:Trimethaphan; D011433:Propranolol; D003000:Clonidine; D003981:Diazoxide; D014223:Triamterene; D011224:Prazosin; D006145:Guanethidine